Litcius/Paper detail

Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cells

Bohwa Han, Yeonju Song, Jeehun Park, Junsang Doh

2022Journal of Controlled Release33 citationsDOI

Topics & Concepts

Ex vivoChimeric antigen receptorImmunotherapyImmune systemCancer immunotherapyCancer researchTumor microenvironmentCell therapyImmunologyIn vivoCell biologyBiologyStem cellBiotechnologyCAR-T cell therapy researchImmune Cell Function and InteractionImmunotherapy and Immune Responses
Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cells | Litcius